Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the first quarter of 2022.
In this edition, COVID cases are still endemic for insurance companies, kids’ contracts are voidable but not void, and crypto can’t escape the Securities Act. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the first quarter.
Class Action MDL Roundup
July 13, 2022
Class Action & MDL Roundup – Q1 2022
-
Cari K. Dawson
-
David Venderbush
-
Ryan P. Ethridge
-
Charlotte M. Bohn
-
David Carpenter
-
F. Nicholas Chandler
-
Sean R. Crain
-
Jamie S. George
-
Bradley Harder
-
Michelle Jackson
- Jyoti Jindal Kottamasu
-
Laura A. Komarek
-
Matthew D. Lawson
-
Andrew J. Liebler
-
Katie Jo Luningham
-
William J. Repko III
-
Noelle Reyes
-
Jason Rottner
-
Troy A. Stram
-
Ellie Studdard
-
Andrew T. Sumner
-
Amanda M. Waide
-
Nick A. Young
Meet the Authors
Senior Associate
Phone:
+1 404 881 7679
Other Phone:
+1 212 905 9156
Email:
nick.chandler@alston.com
Related News & Insights
-
Class Action MDL Roundup Spring 2021Class Action & MDL Roundup – Spring 2021Welcome to the spring edition of the Class Action & MDL Roundup, covering significant decisions and settlements from the first quarter of 2021.
-
Class Action MDL Roundup Winter 2021Class Action & MDL Roundup – Winter 2021Welcome back to the Class Action & MDL Roundup! Our winter edition covers notable class actions from the fourth quarter of 2020.
-
Class Action MDL Roundup Summer 2020Class Action & MDL Roundup – Summer 2020Welcome to the summer edition of the Class Action & MDL Roundup, covering significant decisions and settlements from the second quarter of 2020. We also include new class actions popping up in the wake of the COVID-19 pandemic.
-
Class Action MDL Roundup March 27, 2023Class Action & MDL Roundup 2022 Q4 – A “healthy” dose of litigationIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2022, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup December 20, 2022Class Action & MDL Roundup 2022 Q3 – The very definition of all naturalIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2022, all dog stairs go to heaven, the Third Circuit resets Article III standing, and challenging damages can be aggregating. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact